GlassScriptPhysician profile
Brandon M Sutton
NPI 1790096980
$9,258.95
in general payments reported to CMS, 2019-2025
27 companies · $553 in 2025
The $553 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,722 · 2020: $1,286 · 2021: $954 · 2022: $1,330 · 2023: $2,044 · 2024: $1,368 · 2025: $553.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,912 · Travel and Lodging: $556 · Education: $498.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,912.09 |
| Travel and Lodging | $555.67 |
| Education | $497.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,343.50 | 2019-2025 | Octrode, Proclaim, Penta |
| Relievant Medsystems, INC. | $1,529.98 | 2022-2023 | Intracept |
| Vertos Medical, INC. | $1,064.55 | 2019-2020 | |
| Si-Bone, INC. | $883.52 | 2019-2025 | |
| Boston Scientific Corporation | $726.81 | 2019-2025 | Intracept |
| Saluda Medical Americas, INC. | $92.41 | 2024 | Evoke |
| Amgen INC. | $89.35 | 2023 | Prolia, Evenity |
| Flowonix Medical Incorporated | $54.01 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $52.03 | 2019-2022 | |
| Pfizer INC. | $51.92 | 2019-2021 | |
| Nevro Corp. | $43.99 | 2019 | |
| Spr Therapeutics, INC | $36.22 | 2022-2024 | Sprint Pns System |
| Medtronic USA, INC. | $34.68 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.66 | 2019 | |
| Pacira Therapeutics, INC. | $28.21 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $26.74 | 2023 | Kyphon Express II Kyphopak Tray |
| Grt US Holding, INC. | $21.06 | 2020 | |
| Spinal Simplicity, LLC | $18.94 | 2022 | |
| Hikma Pharmaceuticals USA | $16.72 | 2022 | |
| Allergan, INC. | $16.38 | 2020 | |
| Scilex Pharmaceuticals INC. | $15.60 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.35 | 2022 | |
| Sanofi-Aventis U.S. LLC | $13.40 | 2019 | |
| Stimwave Technologies Incorporated | $12.84 | 2020 | |
| Mdd US Operations, LLC | $12.80 | 2019 | |
| Novartis Pharmaceuticals Corporation | $12.56 | 2019 | |
| Zyla Life Sciences, INC. | $11.72 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.